Clinical Features of Pseudotumour Cerebri Syndrome Syndrome: A Retrospective Evaluation of 60 Patients
PDF
Cite
Share
Request
Research Article
P: 61-65
April 2019

Clinical Features of Pseudotumour Cerebri Syndrome Syndrome: A Retrospective Evaluation of 60 Patients

J Ankara Univ Fac Med 2019;72(1):61-65
1. Sağlık Bilimleri Üniversitesi Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Nöroloji Kliniği, Ankara, Türkiye
No information available.
No information available
Received Date: 30.11.2018
Accepted Date: 04.03.2019
Publish Date: 13.06.2019
PDF
Cite
Share
Request

ABSTRACT

Objectives:

To evaluate the demographic, clinical and radiological characteristics of the patients who are followed up with the diagnosis of pseudotumour cerebri syndrome (PTCS).

Materials and Methods:

The etiological, symptomatic, ophtalmologic, radiological and treatment data of sixty cases that were followed up at the outpatient headache clinic between 2014 and 2018 were retrospectively analyzed.

Results:

Fifty-four female patients having an average age of (36.50±12.37) and 6 male patients having an average age of (33.70±9.17) were included in the study. Mean disease period was 8.91±12.73 months and mean body mass index value was 30.43±5.27. Etiologically, it was due to primary (73.3%) or secondary (26.7%) causes. Headache was present in 91.7% of the patients, tinnitus in 65%, diplopia in 16.7% and papiloedema was present in all the patients. In magnetic resonance imaging, extension of the perioptic subarachnoid space was observed in 26 patients, flattening in the posterior globe in 3 patients, Arnold-Chiari malformation in 1 patient, and empty sella in 9 patients. In the treatment, 43 patients used acetazolamide, 13 patients used acetazolamide and topiramate, 2 patients used acetazolamide, furosemide and topiramate, and 1 patient used topiramate. Optic nerve fenestration was applied to 1 patient.

Conclusion:

Update of the clinical and neuroimaging findings has brought a more detailed approach for the PTCS diagnosis. However, the pathophysiology of PTSS remains unclear. Researches on this regard will enable the development of more effective diagnosis and treatment methods.

Keywords: Idiopathic Intracranial Hypertension, Pseudotumour Cerebri Syndrome, Headache

References

1
Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32:363-396.
2
De Simone R, Ranieri A, Montella S, et al. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2014;82:1011-1012.
3
Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159-1165.
4
McGeeney BE, Friedman DI. Pseudotumor cerebri pathophysiology. Headache. 2014;54:445-458.
5
Julayanont P, Karukote A, Ruthirago D, et al. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. J Pain Res. 2016;9:87-99.
6
Thurtell MJ, Bruce BB, Newman NJ, et al. An update on idiopathic intracranial hypertension. Rev Neurol Dis. 2010 Spring-Summer;7:e56-68.
7
Headache Classification Committee of the International Headache Society (IHS). The International Classification of HeadacheDisorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808.
8
Mallery RM, Friedman DI, Liu GT. Headache and the pseudotumor cerebri syndrome. Curr Pain Headache Rep. 2014;18:446.
9
Lim M, Kurian M, Penn A, et al. Visual failure without headache in idiopathic intracranial hypertension. Arch Dis Child. 2005;90:206-210.
10
Eren Y, Kabataş N, Güngör Yavaşoğlu N, et al. Idiopathic intracranial hypertension without headache: A case report and literature review. Agri. 2018;30:142-145.
11
Mollan SP, Markey KA, Benzimra JD, et al. A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol. 2014;14:380-390.
12
Skau M, Yri H, Sander B, et al. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2013;251:567-574.
13
Waisbourd M, Leibovitch I, Goldenberg D, et al. OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2011;113:839-843.
14
Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, et al. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2015;130:122-127.
15
Eren Y, Kabatas N, Guven H, et al. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension. Acta Neurol Belg. 2018;17.
16
Akçakaya NH, Akçakaya MO, Sencer A. İdiyopatik İntrakraniyal Hipertansiyon: Tanı ve Tedavi Yaklaşımı Turk J Neurol 2017;23:43-50
17
Bidot S, Saindane AM, Peragallo JH, et al. Brain Imaging in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2015;35:400-411.
2024 ©️ Galenos Publishing House